https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Celia Gutierrez Villegas from the IDIVAL Nursing research group, awarded for a study on the economic impact of COPD in Cantabria.

12 de February de 2025

Celia Gutiérrez Villegas, a nurse from the IDIVAL nursing research group and the Primary Care Management of the Cantabrian Health Service, has been awarded second prize in the Community and Social Sphere category of the 4th Research Awards of the General Nursing Council (CGE). Her project, entitled Analysis of the costs of Chronic Obstructive Pulmonary […]

Read more →

11 de February de 2025

The Marqués de Valdecilla Research Institute (IDIVAL) has launched a new technological support platform, the Metabolomics Unit, an innovative technological service designed to strengthen biomedical research through the advanced analysis of metabolites. With this initiative, IDIVAL reaffirms its commitment to scientific excellence through the application of cutting-edge tools in the field of health. Thanks to […]

Read more →

A hopeful breakthrough in the treatment of Multiple Myeloma

6 de February de 2025

The Haematology Service of the Marqués de Valdecilla University Hospital, in collaboration with IDIVAL, has participated in an international clinical trial that opens up new possibilities in the treatment of Multiple Myeloma, a type of blood cancer that is difficult to treat. The results have been published in the New England Journal of Medicine, one […]

Read more →

4 de February de 2025

The Spanish Foundation for Science and Technology (FECYT), in collaboration with Clarivate, has announced a new Web of Science Online Workshop, aimed exclusively at managers, librarians and administrators who already use this database in their institutions. Registration for this workshop is now available and, as noted, is restricted to only those managers, librarians and administrators […]

Read more →

IDIVAL organises the conference ‘Your Health, Our Priority’ on the European programme EU4Health

3 de December de 2024

Next Thursday, 12 December, the Valdecilla Research Institute (IDIVAL), in collaboration with the Carlos III Health Institute (ISCIII) and the Ministry of Health, will hold the conference ‘Your Health, Our Priority’ at the Marqués de Valdecilla University Hospital (Gómez Durán Hall). This event, which is free of charge and open to the general public with […]

Read more →

Marqués de Valdecilla University Hospital holds a conference on Difficult to Treat Depression and Suicide Prevention

28 de November de 2024

The Psychiatry Service of the Marqués de Valdecilla University Hospital has developed the ‘Centre of Excellence for Difficult-to-treat Depression and Suicide Prevention’ programme, reaffirming its commitment to the comprehensive care of these disorders due to their functional, social and economic impact, as well as the risk they pose to patients’ lives. This programme combines a […]

Read more →

Newsletter No. 352, December 21

4 de April de 2024
Read more →

IDIVAL and the Optics Group of the University of Cantabria collaborate to advance in glioblastoma surgery through the use of light

21 de March de 2024

The work will allow the development of an optical sensor for the precise identification of tumour margins. Researchers from the Cell Signalling and Therapeutic Targets in Cancer Group of the Valdecilla Research Institute (IDIVAL) and the Optics Group of the University of Cantabria (UC) are collaborating in the development of an optical sensor to aid […]

Read more →

IDIVAL and HUMV organize a course on Generative Artificial Intelligence in basic and/or clinical research

4 de March de 2024

Registrations are open for the seminar that will delve into the types, uses and ethical issues of generative artificial intelligence. Next Monday March 11 will be held the training course called ‘How to improve your workflows with generative AI in basic and/or clinical research’ which will take place in the afternoon (16h to 20h) in […]

Read more →

The Group of Neurodegenerative Diseases at IDIVAL reveals factors that may influence early diagnosis of Alzheimer’s disease

8 de February de 2024

Previous hypertension, diabetes and renal insufficiency could alter plasma markers A multidisciplinary research team belonging to the Neurodegenerative Diseases Group of IDIVAL and the Cognitive Impairment Unit of the Neurology Service of the Marqués de Valdecilla University Hospital (HUMV) has conducted a study aimed at understanding how different physiological variables and previous diseases could influence […]

Read more →